Concert Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
5 Stocks To Bet On New Analyst Coverage
Article By: Zacks Investment Research
Monday, August 21, 2017 12:32 PM EDT
As analysts are one of the most important information intermediaries in capital markets, initiation of coverage by them creates value for companies.
In this article: CMCO, ACET, CNCE, APPF, FWONA
After Valeant, Here Are 5 Drug Stocks Bill Ackman Should Buy Instead
Article By: Arpita Dutt
Wednesday, March 15, 2017 12:57 PM EDT
Here is a look at 5 drug stocks that could find a place in Ackman’s investment plans.
In this article: NEOS, CNCE, LOXO, NDRM, BCRX Also: VRX
Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains On Vertex Deal
Article By: Arpita Dutt
Wednesday, March 8, 2017 9:08 AM EDT
A tweet kept the biotech industry on edge with President Donald Trump declaring that he is “working on a new system where there will be competition in the Drug Industry” and “pricing for the American people will come way down”.
In this article: CNCE, IONS, JUNO, CELG Also: VRTX, GILD, BIIB
Monday’s Biotech Insights: Concert Pharmaceuticals Inc (CNCE), TG Therapeutics Inc (TGTX)
Article By: Smarter Analyst
Monday, March 6, 2017 3:58 PM EDT
CNCE shares skyrocketed today following the news that Vertex Pharmaceuticals (NASDAQ:VRTX) will acquire Concert’s deuterated Kalydeco variant, CTP-656, for $160 million upfront with up to $90 million in milestones.
In this article: CNCE, VRTX
Concert Pharmaceutical - Chart Of The Day
Article By: Jim Van Meerten
Monday, October 19, 2015 10:00 PM EDT
Since the Trend Spotter signaled a buy on 9/9 the stock gained 33.80%.
In this article: CNCE

Latest Tweets for $CNCE

No tweets yet!



After Valeant, Here Are 5 Drug Stocks Bill Ackman Should Buy Instead
Mitch Reynolds 3/15/2017 6:34:03 PM

Great stock picks, thanks for the insight. $NEOS $CNCE $LOXO $NDRM $BCRX

1 to 1 of 1 comments